Table 2.

Plasma KIM-1 and NGAL levels at dual comparisons using all sampling time (0h-2h, 0h-24h, 2h-24h)

	0.h	2.h	24.h	p*	p1	p2	p3
	Mean±SD Median (Min–Max)	Mean±SD Median (Min–Max)	Mean±SD Median (Min–Max)
KIM1 (ng/mL)
Control	0.31±0.09	0.35±0.04	0.76±0.14	0.009	0.400	0.028	0.028
	0.31 (0.2–0.4)	0.35 (0.3–0.39)	0.75 (0.59–0.96)
Trauma	0.28±0.08	5.59±1	11.2±1.02	0.001	0.012	0.012	0.012
	0.31 (0.2–0.4)	6 (3.29–6.33)	10.9 (10.1–12.7)
NGAL (ng/mL)
Control	3.72±0.5	4.29±0.6	4.54±0.16	0.030	0.028	0.018	0.176
	3.79 (2.9–4.3)	4.2 (3.57–5.09)	4.54 (4.29–4.75)
Trauma	3.69±0.5	19.51±4.22	51.1±1.7	0.001	0.012	0.012	0.012
	3.94 (2.9–4.3)	21.2 (11.0–22.6)	51.6 (50.5–55.9)

^*Friedman test p<0.05,

¹0h-2h,

²0h-24h,

³2h-24h. KIM-1: Bioassay Technology Laboratory E0549Ra, Rat kidney Injury Molecule-1; NGAL: Bioassay TechnologyE0762Ra, Rat neutrophil gelatinase associated lipocalin; SD: Standard deviation; Min: Minimum; Max: Maximum.